Actinium Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) a leader in the development of targeted radiotherapies for...

Related Keywords

New York ,United States ,Memorial Sloan Kettering Cancer Center ,Hans Vitzthum ,Lifesci Advisors ,Lotte New York Palace Hotel ,Exchange Commission ,Astellas Pharma Inc ,Actinium Pharmaceuticals Inc ,Epicentrx Inc ,Prnewswire Actinium Pharmaceuticals Inc ,Annual Global Investment Conference ,Global Investment Conference ,Actinium Pharmaceuticals ,Antibody Radiation Conjugates ,Bone Marrow Transplant ,Gene Therapy ,Adoptive Cell Therapy ,Elderly Relapsed ,Refractory Acute Myeloid Leukemia ,Memorial Sloan Kettering Cancer ,Antibody Warhead Enabling ,Astellas Pharma ,Looking Statements ,Sci Advisors ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Trade Show News ,